These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

243 related items for PubMed ID: 27342579

  • 1. Iron-related parameters in dialysis patients treated with sucroferric oxyhydroxide.
    Covic AC, Floege J, Ketteler M, Sprague SM, Lisk L, Rakov V, Rastogi A.
    Nephrol Dial Transplant; 2017 Aug 01; 32(8):1330-1338. PubMed ID: 27342579
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Sucroferric oxyhydroxide for the treatment of hyperphosphatemia.
    Sprague SM, Floege J.
    Expert Opin Pharmacother; 2018 Jul 01; 19(10):1137-1148. PubMed ID: 29985725
    [Abstract] [Full Text] [Related]

  • 11. Long-term efficacy and safety of sucroferric oxyhydroxide in African American dialysis patients.
    Sprague SM, Ketteler M, Covic AC, Floege J, Rakov V, Walpen S, Rastogi A.
    Hemodial Int; 2018 Oct 01; 22(4):480-491. PubMed ID: 29656600
    [Abstract] [Full Text] [Related]

  • 12. Efficacy and safety of sucroferric oxyhydroxide compared with sevelamer hydrochloride in Japanese haemodialysis patients with hyperphosphataemia: A randomized, open-label, multicentre, 12-week phase III study.
    Koiwa F, Yokoyama K, Fukagawa M, Terao A, Akizawa T.
    Nephrology (Carlton); 2017 Apr 01; 22(4):293-300. PubMed ID: 27496336
    [Abstract] [Full Text] [Related]

  • 13. Efficacy and Safety of Sucroferric Oxyhydroxide Compared with Sevelamer Carbonate in Chinese Dialysis Patients with Hyperphosphataemia: A Randomised, Open-Label, Multicentre, 12-Week Phase III Study.
    Liu J, Zuo L, Walpen S, Bernard L, Marty M, Enoiu M.
    Nephron; 2024 Apr 01; 148(1):22-33. PubMed ID: 37473746
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Sucroferric oxyhydroxide, a novel iron-based phosphate binder. Which current use in dialysis patients?].
    Bataille P, Delattre V, Daroux M.
    Nephrol Ther; 2017 Apr 01; 13 Suppl 1():S103-S108. PubMed ID: 28577730
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Preclinical Pharmacokinetics, Pharmacodynamics and Safety of Sucroferric Oxyhydroxide.
    Cozzolino M, Funk F, Rakov V, Phan O, Teitelbaum I.
    Curr Drug Metab; 2014 Apr 01; 15(10):953-65. PubMed ID: 25658128
    [Abstract] [Full Text] [Related]

  • 18. Pharmacodynamic Effects of Sucroferric Oxyhydroxide and Sevelamer Carbonate on Vitamin D Receptor Agonist Bioactivity in Dialysis Patients.
    Sprague SM, Covic AC, Floege J, Ketteler M, Botha J, Chong EM, Rastogi A.
    Am J Nephrol; 2016 Apr 01; 44(2):104-12. PubMed ID: 27434393
    [Abstract] [Full Text] [Related]

  • 19. Effects of Sucroferric Oxyhydroxide Compared to Lanthanum Carbonate and Sevelamer Carbonate on Phosphate Homeostasis and Vascular Calcifications in a Rat Model of Chronic Kidney Failure.
    Phan O, Maillard M, Malluche HH, Stehle JC, Funk F, Burnier M.
    Biomed Res Int; 2015 Apr 01; 2015():515606. PubMed ID: 26221597
    [Abstract] [Full Text] [Related]

  • 20. The real-world effectiveness of sucroferric oxyhydroxide in European hemodialysis patients: a 1-year retrospective database analysis.
    Ramos R, Chazot C, Ferreira A, Di Benedetto A, Gurevich K, Feuersenger A, Wolf M, Arens HJ, Walpen S, Stuard S.
    BMC Nephrol; 2020 Dec 07; 21(1):530. PubMed ID: 33287733
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.